Seattle Genetics (SGEN) Reports In-Line Q1 EPS
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/11/2026
- S&P 500 ends higher as strong inflation data cements rate-hike bets
- Oracle raises full year profit guidance, stock rises after hours
- Oil falls but head for 8% weekly gain on tight supply; US diesel hits record
- 'No panic anywhere' may be the problem, BofA strategists warn
- Buy Shopify stock at this ’AI-enabled entry point,’ analyst says
- After-Hours Movers: ORCL, CRWV, ADBE, ACVA, CPRT, ZUMZ, PMTS, RH
- After-Hours Movers: COO, AEO, NAVN, AVAV, TORO
- After-Hours Movers: LULU, IOT, PATH, DOCU, ASAN, GWRE, ZS, PL, SWBI, OXM
- After-Hours Movers: AVGO, SNOW, HPE, NTAP, NTSK, CHPT, FIVE, TLYS, PVH, RARE
- After-Hours Movers: DELL, PANW, GTLB, CRDO, MDB, HPE, SMCI
Seattle Genetics (SGEN) PT Raised to $75 at H.C. Wainwright; ' Like Commercial Progress & Pipeline Diversification'
April 28, 2017 7:25 AM EDTH.C. Wainwright raised its price target on Seattle Genetics (NASDAQ: SGEN) to $75.00 (from $65.00) while maintaining a Buy rating, following a first quarter financial update and model revision.
Analyst Andrew Fein notes fundamental strength in the company's underlying business, both commercial and experimental, with... More
